DUBLIN, Sept. 7, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced detailed positive results from the Vibrance-1 phase 2 study evaluating alixorexton in patients with narcolepsy type 1 ...
Researchers believe there's an upper limit to the temperature the human body can withstand — but many people could face deadly health problems before reaching that threshold.
Type 1 narcolepsy is often more severe and includes cataplexy, which is sudden muscle weakness triggered by emotions. Both type 1 and type 2 narcolepsy cause excessive daytime sleepiness, but people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback